Turning Point Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
CUI JINGRONG JEAN director
 Common Stock 7,000 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 11,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 11,500 $61.45 $706,618
Sale
CUI JINGRONG JEAN director
 Common Stock 18,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 18,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 18,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 7,000 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 7,000 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 7,000 $58.4 $408,779
Sale
CUI JINGRONG JEAN director
 Common Stock 7,000 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 11,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 18,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 18,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 18,500 N/A N/A
Option
CUI JINGRONG JEAN director
 Stock Option (right to buy) 16,864 N/A N/A
Option
CUI JINGRONG JEAN director
 Common Stock 16,864 N/A N/A
Option
CUI JINGRONG JEAN director
 Stock Option (right to buy) 38,080 N/A N/A
Option
CUI JINGRONG JEAN director
 Common Stock 38,080 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 11,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 18,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 18,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 18,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 11,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 11,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 11,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 11,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 11,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 11,500 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 50,890 N/A N/A
Sale
CUI JINGRONG JEAN director
 Common Stock 56,110 N/A N/A
Purchase
LARSON YI officer: EVP & Chief Financial ..
 Common Stock 2,222 N/A N/A
Purchase
COUNTOURIOTIS ATHENA director, officer: President & ..
 Common Stock 10,000 N/A N/A
Purchase
GLAXOSMITHKLINE PLC director
 Common Stock 177,777 N/A N/A
Purchase
GEORGE SIMEON director
 Common Stock 177,777 N/A N/A
Option
CUI JINGRONG JEAN director
 Stock Option (right to buy) 54,220 N/A N/A
Option
CUI JINGRONG JEAN director
 Common Stock 54,220 N/A N/A
Option
CORMORANT ASSET MANAGEMENT, LP other: Former 10% Owner
 Common Stock 23,268 N/A N/A
Option
CORMORANT ASSET MANAGEMENT, LP other: Former 10% Owner
 Stock Options (right to buy) 23,268 N/A N/A
Purchase
CORMORANT ASSET MANAGEMENT, LP other: Former 10% Owner
 Common Stock 400,000 N/A N/A
Purchase
BAKER BRIAN LEE officer: SVP of Finance and Adm..
 Common Stock 2,800 N/A N/A
Purchase
COUNTOURIOTIS ATHENA director, officer: President & ..
 Common Stock 12,000 N/A N/A
Purchase
ORBIMED ADVISORS LLC director
 Common Stock 360,000 N/A N/A
Purchase
GLAXOSMITHKLINE PLC director
 Common Stock 325,000 N/A N/A
Purchase
GORDON CARL L director
 Common Stock 360,000 N/A N/A
Purchase
GEORGE SIMEON director
 Common Stock 325,000 N/A N/A
Purchase
LU HONGBO director
 Common Stock 60,000 N/A N/A

Showing 100 to 146 of 146 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: